Pacific Cancer Care-Monterey — Monterey, California

Pacific Cancer Care-Monterey is a clinical research site located in Monterey, California, United States 93940.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Pacific Cancer Care-Monterey has participated in 9 clinical trials with 3 currently active.

Therapeutic areas: Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, Advanced Unresectable or Metastatic Solid Malignancy.

Sponsors: SWOG Cancer Research Network, Genentech, Inc., National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Monterey

Browse all research sites in California · View every site in Monterey

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pacific Cancer Care-Monterey?

Pacific Cancer Care-Monterey has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pacific Cancer Care-Monterey conducted?

Pacific Cancer Care-Monterey has 9 clinical trials on record, with 3 currently active. Their work covers Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, Advanced Unresectable or Metastatic Solid Malignancy.

Is Pacific Cancer Care-Monterey accredited by Crixeo Clinical Trials?

Pacific Cancer Care-Monterey has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pacific Cancer Care-Monterey?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.